Antiplatelets or anticoagulants? Secondary prevention in cervical artery dissection: an updated meta-analysis

Extracranial artery dissection involving either internal carotid artery or vertebral artery is a major cause of stroke in adults under 50 years of age. There is no conclusive evidence whether antiplatelets or anticoagulants are better suited in the treatment of extracranial artery dissection. To det...

Full description

Saved in:
Bibliographic Details
Published in:Neurological research and practice 2022-06, Vol.4 (1), p.23-12, Article 23
Main Authors: The, Ei Zune, Lin, Ne Naing, Chan, Ching Jocelyn, Loon, Jason Cher Wei, Tan, Benjamin Yong-Qiang, Seet, Chee Seong Raymond, Teoh, Hock Luen, Vijayan, Joy, Yeo, Leong Litt Leonard
Format: Article
Language:English
Subjects:
Anticoagulants
Aspirin
Carotid artery
Death
Dissection
Extracranial artery dissection
Internal carotid artery
Ischemia
Meta-analysis
Review
Secondary prevention
Statistical analysis
Stroke
Transient ischemic attack
Vertebrae
Vertebral artery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Extracranial artery dissection involving either internal carotid artery or vertebral artery is a major cause of stroke in adults under 50 years of age. There is no conclusive evidence whether antiplatelets or anticoagulants are better suited in the treatment of extracranial artery dissection. To determine whether antiplatelets or anticoagulants have advantage over the other in the treatment of extracranial artery dissection for secondary prevention of recurrent ischemic events or death. Present meta-analysis followed Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 statement. Database search was done in Medline, Cochrane Central Register of Controlled Trials (CENTRAL) and ClinicalTrials.gov from inception to May 2021 using pre-defined search strategy. Additional studies were identified from reference lists from included studies, reviews and previous meta-analyses. Outcome measures were ischaemic stroke, ischaemic stroke or transient ischaemic attack (TIA), and death. Two RCTs and 64 observational studies were included in the meta-analysis. While the outcome measures of stroke, stroke or TIA and death were numerically higher with antiplatelet use, there were no statistically significant differences between antiplatelets and anticoagulants. We found no significant difference between antiplatelet and anticoagulation treatment after extracranial artery dissection. The choice of treatment should be tailored to individual cases.
ISSN:2524-3489
2524-3489
DOI:10.1186/s42466-022-00188-7